Related Experiment Video

Updated: Jun 13, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

Vorasidenib: a new hope or a false promise for patients with low-grade glioma?

Stanislav Lazarev1, Kunal K Sindhu2

  • 1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. stanislav.lazarev@mountsinai.org.

Nature Reviews. Clinical Oncology
|September 12, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Related Experiment Videos

Last Updated: Jun 13, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

Articles linked to this work by shared authors, journal, and citation graph.

The Utility of Tumor Tissue-Modified Viral HPV DNA Testing for HPV-Associated Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.

Head & neck·2026

Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026

Structural Vulnerability in the United States Radiation Oncology Delivery System: Predictors and Consequences of Practice Site Disappearance.

International journal of radiation oncology, biology, physics·2026

Radiotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: Current Evidence and Future Directions.

Current oncology (Toronto, Ont.)·2026

Collateral Damage: How Medicaid Cuts Under the One Big Beautiful Bill Act Threaten Rural Radiation Oncology.

Cureus·2026

The Holman Research Pathway in Diagnostic Radiology: 2003-2023.

Journal of the American College of Radiology : JACR·2025

Optimizing the delivery of radiotherapy with artificial intelligence.

Nature reviews. Clinical oncology·2026

Understanding and targeting the tumour matrisome.

Nature reviews. Clinical oncology·2026

Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology.

Nature reviews. Clinical oncology·2026

Exploring the landscape of targetable alterations in patients with glioblastoma.

Nature reviews. Clinical oncology·2026

AI-based augmentation of oncology clinical trials.

Nature reviews. Clinical oncology·2026

Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

Nature reviews. Clinical oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us